Biocartis Group Nv Stock Retained Earnings
BCART Stock | EUR 0.29 0.00 0.00% |
Biocartis Group NV fundamentals help investors to digest information that contributes to Biocartis Group's financial success or failures. It also enables traders to predict the movement of Biocartis Stock. The fundamental analysis module provides a way to measure Biocartis Group's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biocartis Group stock.
Biocartis |
Biocartis Group NV Company Retained Earnings Analysis
Biocartis Group's Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
More About Retained Earnings | All Equity Analysis
Retained Earnings | = | Beginning RE + Income | - | Dividends |
Current Biocartis Group Retained Earnings | (188 M) |
Most of Biocartis Group's fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biocartis Group NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
Competition |
Based on the latest financial disclosure, Biocartis Group NV has a Retained Earnings of (188 Million). This is 120.19% lower than that of the Health Care Equipment & Supplies sector and 128.92% lower than that of the Health Care industry. The retained earnings for all Belgium stocks is 102.02% higher than that of the company.
Did you try this?
Run Price Exposure Probability Now
Price Exposure ProbabilityAnalyze equity upside and downside potential for a given time horizon across multiple markets |
All Next | Launch Module |
Biocartis Fundamentals
Return On Equity | -48.84 | |||
Return On Asset | -0.22 | |||
Profit Margin | (1.07) % | |||
Operating Margin | (0.85) % | |||
Current Valuation | 182.31 M | |||
Shares Outstanding | 93.1 M | |||
Shares Owned By Insiders | 6.66 % | |||
Shares Owned By Institutions | 27.71 % | |||
Price To Earning | (9.91) X | |||
Price To Book | 6.47 X | |||
Price To Sales | 0.89 X | |||
Revenue | 48.27 M | |||
Gross Profit | (25.72 M) | |||
EBITDA | (52.55 M) | |||
Net Income | (71.47 M) | |||
Cash And Equivalents | 53.52 M | |||
Cash Per Share | 0.93 X | |||
Total Debt | 128.15 M | |||
Debt To Equity | 40.40 % | |||
Current Ratio | 2.82 X | |||
Book Value Per Share | (1.07) X | |||
Cash Flow From Operations | (65.72 M) | |||
Earnings Per Share | (1.24) X | |||
Target Price | 1.8 | |||
Number Of Employees | 619 | |||
Beta | 1.51 | |||
Market Capitalization | 60.8 M | |||
Total Asset | 142.48 M | |||
Retained Earnings | (188 M) | |||
Working Capital | 90 M | |||
Current Asset | 118 M | |||
Current Liabilities | 28 M | |||
Z Score | -1.4 | |||
Net Asset | 142.48 M |
About Biocartis Group Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biocartis Group NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biocartis Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biocartis Group NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Other Information on Investing in Biocartis Stock
Biocartis Group financial ratios help investors to determine whether Biocartis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biocartis with respect to the benefits of owning Biocartis Group security.